Introduction:Basic information about CAS 149003-01-0|Dexrazoxane HCl (ICRF-187, ADR-529), including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Dexrazoxane HCl (ICRF-187, ADR-529) |
|---|
| CAS Number | 149003-01-0 | Molecular Weight | 304.73000 |
|---|
| Density | / | Boiling Point | 531.5ºC at 760 mmHg |
|---|
| Molecular Formula | C11H17ClN4O4 | Melting Point | 193ºC |
|---|
| MSDS | / | Flash Point | 275.3ºC |
|---|
Names
| Name | dexrazoxane hydrochloride |
|---|
| Synonym | More Synonyms |
|---|
Dexrazoxane HCl (ICRF-187, ADR-529) BiologicalActivity
| Description | Dexrazoxane Hcl( ICRF-187 Hcl) is a cardioprotective agent. IC50 value:Target: cardioprotective agentAs a derivative of EDTA, dexrazoxane chelates iron, thus reduce the number of metal ions complexed with anthracycline and, consequently, decrease the formation of superoxide radicals. This agent is used to protect the heart against the cardiotoxic side effects of anthracyclines, such as doxorubicin. It was speculated that dexrazoxane could be used for further investigation to synthesize new antimalarial drugs. |
|---|
| Related Catalog | Signaling Pathways >>Others >>OthersResearch Areas >>Cardiovascular Disease |
|---|
| References | [1]. Hasinoff BB. The use of dexrazoxane for the prevention of anthracycline extravasation injury. Expert Opin Investig Drugs. 2008 Feb;17(2):217-23. [2]. Jones RL. Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicity. Expert Rev Cardiovasc Ther. 2008 Nov;6(10):1311-7. [3]. Lipshultz SE, Scully RE, Lipsitz SR et al. Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. Lancet Oncol. 201 |
|---|
Chemical & Physical Properties
| Boiling Point | 531.5ºC at 760 mmHg |
|---|
| Melting Point | 193ºC |
|---|
| Molecular Formula | C11H17ClN4O4 |
|---|
| Molecular Weight | 304.73000 |
|---|
| Flash Point | 275.3ºC |
|---|
| Exact Mass | 304.09400 |
|---|
| PSA | 98.82000 |
|---|
| Vapour Pressure | 2.22E-11mmHg at 25°C |
|---|
| InChIKey | BIFMNMPSIYHKDN-FJXQXJEOSA-N |
|---|
| SMILES | CC(CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1.Cl |
|---|
| Storage condition | -20°C |
|---|
Safety Information
Synonyms
| 2,6-Piperazinedione, 4-[(1S)-2-(3,5-dioxo-1-piperazinyl)-1-methylethyl]-, hydrochloride (1:1) |
| 4,4'-(2S)-Propan-1,2-diyldipiperazin-2,6-dionhydrochlorid |
| 4,4'-(2S)-propane-1,2-diyldipipérazine-2,6-dione chlorhydrate |
| (S)-4,4'-(1-Methyl-1,2-ethanediyl)bis-2,6-piperazinedionehydrochloride |
| Dexrazoxane hydrochloride |
| 2,6-Piperazinedione, 4,4'-[(1S)-1-methyl-1,2-ethanediyl]bis-, hydrochloride (1:1) |
| 4,4'-[(2S)-1,2-Propanediyl]di(2,6-piperazinedione) hydrochloride (1:1) |
| 2,6-piperazinedione, 4,4'-[(1S)-1-methyl-1,2-ethanediyl]bis-, monohydrochloride |
| 4,4'-(2S)-Propane-1,2-diyldipiperazine-2,6-dione hydrochloride (1:1) |
| Dexrazoxane HCl |
| UNII:5346058Q7S |
| Dexrazoxane (Hydrochloride) |